tirzepatide in indianapolis Lilly Files Lawsuit Against Spa for Selling Repackaged Zepbound Lilly Increases Manufacturing Investment to
Description
Eli Lilly forecast a 2026 profit of $33.50 to $35 per share, with the low end of the range above analysts average estimate of $33.23, according to LSEG data
Email your PCC
Acute Gallbladder Disease: Tirzepatide may cause gallbladder problems, including gallstones
Lillys successes have boosted its market value to more than $1 trillion, the first pharmaceutical company to reach that milestone, while Novo shares have sunk 40% over the last year
A Texas Judge on Wednesday took Eli Lilly s side in its ongoing court battle over compounded versions of its blockbuster GLP-1 drug tirzepatide, according to reporting from Reuters
